SCHEMBL7430491

SCHEMBL7430491

NC(=NCCCc1c[nH]cn1)NCCOC(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EBP Q15125 1/20 0.40
SIGMAR1 Q99720 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7433411 0.86
SCHEMBL9865115 0.83 HRH4 (0.39)
SCHEMBL9828132 0.83 KDM1A (0.44)
SCHEMBL9867357 0.82 SCN5A (0.43)
SCHEMBL9828417 0.82 KDM1A (0.47)
SCHEMBL9867126 0.81 HRH4 (0.47)
SCHEMBL7315384 0.81 NPY1R (0.49)
SCHEMBL7295398 0.81
SCHEMBL9771022 0.81 SIGMAR1 (0.43) SIGMAR1
SCHEMBL9865960 0.80 SCN5A (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0448765-B1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1994-08-17 EP claimed
EP-0448765-A1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1991-10-02 EP claimed
EP-0448765-B1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1994-08-17 EP disclosed
EP-0448765-A1 Use of guanidine derivatives for the manufacture of a medicament with NPY-antagonistic activity HEUMANN PHARMA GMBH & CO (DE) 1991-10-02 EP disclosed
EP-0302896-B1 N-(W-SUBSTITUTED ALKYL)-N'-[(IMIDAZOLE-4-YL)ALKYL]GUANIDINE CEDONA PHARMACEUTICALS B.V. (NL) 1991-08-14 EP disclosed
US-5010095-A Antiallergens, congestive heart failure CEDONA PHARMACEUTICALS B.V. (NL) 1991-04-23 US disclosed